Metabolomics Market is expanding at a CAGR of 17.1% from 2016 to 2024

Metabolomics helps in identification and quantification of cellular metabolites with the help of refined analytical technologies with the use of statistical and multi-variant methods for information mining and understanding of the data. Metabolomics provides a direct functional information of the physiological state of an organism. Several analytical technologies have been employed to examine metabolites in different organisms, tissues, or fluids. With the wide range of applications of metabolomics such as phenotyping of genetically modified plants and significant equivalence testing, determination of gene function, and monitoring responses to biotic and abiotic stress the demand for metabolomics is increasing across the globe. Metabolomics is useful for bridging the gap between genotype and phenotype by providing complete view of cell functioning, in addition to identification of novel alterations in certain metabolites. The demand for metabolomics is expected to increase further as examination and data mining of metabolomics data sets and their metadata can lead to different hypotheses and different targets for biotechnology.

Metabolomics is gaining importance as a tool in life science, since it is a relatively fast and precise technique that can be applied with either a particular focus or in an overall manner to gain new knowledge about biological systems. The global metabolomics market is segmented into three sub-segments by techniques, applications, and geography. The market by technique is further divided as separation techniques and detection techniques. Separation techniques includes gas chromatography, capillary electrophoresis, high performance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC). The HPLC accounted for the highest share of metabolomics market by technique. Detection technique includes nuclear magnetic resonance spectroscopy (NMR), mass spectrometry (MS) and others. The market by application includes drug assessment, biomarker discovery, nutrigenomics, clinical toxicology and others. The market by geography is divided into five regions as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Read Full Report:

In a time of exceptional scientific advances and technological developments, personalized health care provides information to detect the onset of disease at in early stage, prevents the progression of disease, and, simultaneously, increases the effectiveness of the health care system by refining quality, availability, and affordability. The great opportunity for personalized medicine is its possibility to introduce novel scientific, business, and medical models. There is a high prevalence of chronic degenerative diseases such as cardiovascular diseases, neurodegenerative disorders, cancer etc. in developed countries. Factors such as unhealthy dietary habits, sedentary lifestyles, and habits such as smoking and alcohol consumption are additionally contributing to the increase in obesity, diabetes, heart disease, stroke and other medical disorders especially in developing countries. With the growing unmet medical needs, the importance of personalized medicine is rising across the globe. With the increase in the demand for personalized medicines, the demand for metabolomics is expected to increase across the globe. Moreover, increasing government funding for research in metabolomics is another factor contributing to the growth of the metabolomics market.

Download exclusive Sample of this report:

The market overview section of the report demonstrates major market dynamics such as drivers, restraints, and opportunities that influence the current and future status of the industry. Porter’s five forces analysis provides information about the competitiveness of the industry. Moreover, the market attractiveness and competitive landscape provided in the market overview gives information about the lucrative markets for investment and major players in this market, respectively. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments.

Major players in this market are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc.(U.S.), Biocrates Life Sciences AG (Austria), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Human Metabolome Technologies, Inc.(Japan), LECO Corporation (U.S.), Metabolon, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), and Bruker Corporation (U.S.)

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453